Precipio, Inc. (NASDAQ:PRPO)
| Market Cap | 39.19M+20.0% |
| Revenue (ttm) | 27.46M+33.5% |
| Net Income | -1.22M+32.5% |
| EPS | -0.65+46.4% |
| Shares Out | 1.79M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 23,746 |
| Open | 21.86 |
| Previous Close | 21.38 |
| Day's Range | 21.46 - 22.22 |
| 52-Week Range | 18.00 - 33.63 |
| Beta | 1.30 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 16, 2026 |
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About PRPO
Precipio, Inc., based in New Haven, Connecticut, functions as a healthcare solutions provider within the United States. The company delivers a range of diagnostic products, reagents, and services, specifically offering diagnostic testing for blood cancers. Its advanced offerings include IV-Cell, a unique cell culture media capable of simultaneously growing four types of hematopoietic cell lineages, and HemeScreen, a comprehensive collection of genetic diagnostic panels. Precipio also develops COVID-19 antibody tests. A notable proprietary innovation is ICE-COLD PCR, a patented technology designed to boost the sensitivity of molecular tests, with kits for this technology also sold to biopharmaceutical customers. Additionally, Precipio, Inc. collaborates with academic institutions dedicated to cancer research, diagnosis, and therapy.
$PRPO stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in PRPO holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by PRPO's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
PRPO Estimated quarterly lobbying spending
Source: U.S. Senate LDA
PRPO Revenue by Segment or Geography
| Segment | Revenue | % of All |
|---|---|---|
| Revenue, net of contractual allowances and adjustments | $7.02M | 53.45% |
| Service revenue, net | $6.12M | 46.55% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New PRPO patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to PRPO from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in PRPO
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $941.14K |
| VXFVanguard Extended Market ETF | $419.02K |
| IWCiShares Micro-Cap ETF | $107.69K |
| DFMCU.S. Micro Cap Portfolio ETF | $55.92K |
| DFASDimensional - US Small Cap ETF | $38.07K |
| DFSUDimensional - US Sustainability Core 1 ETF | $21.55K |
Estimated from each fund’s disclosed top holdings × AUM
PRPO Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from PRPO’s recent data — informational, not investment advice